[Levofloxacin].
Azanza
J R
JR
Sádaba
B
B
Quetglas
E G
EG
Escolar
M
M
D000293:Adolescent; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D002648:Child; D002986:Clinical Trials as Topic; D000075202:Contraindications; D004352:Drug Resistance, Microbial; D004827:Epilepsy / Q000139:chemically induced; D005260:Female; D006801:Humans; D008658:Inactivation, Metabolic; D007231:Infant, Newborn; D064704:Levofloxacin; D008297:Male; D015242:Ofloxacin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D010787:Photosensitivity Disorders / Q000139:chemically induced; D011247:Pregnancy; D014018:Tissue Distribution
D000890:Anti-Infective Agents; D064704:Levofloxacin; D015242:Ofloxacin
Levofloxacino.